SYNTHESIS, SPECTRAL CHARACTERIZATION, AND IN VITRO ANTIMICROBIAL EVALUATION OF NOVEL 1, 3,4-OXADIAZOLE DERIVATIVES

Vidit Sharma, Mrs. Renu*, Mr. Ravi Kumar Saini, Dr. Omprakash Goshain

ABSTRACT

Background: The rapid emergence of antimicrobial resistance has become a major global health concern, necessitating the discovery of new antimicrobial agents with improved efficacy and novel mechanisms of action. Among nitrogen-containing heterocyclic compounds, 1,3,4-oxadiazole derivatives have attracted considerable attention due to their broad spectrum of biological activities, including antibacterial and antifungal properties. Their structural versatility and favorable pharmacological characteristics make them promising candidates for the development of new antimicrobial therapeutics. Objective: The present study aimed to synthesize a series of novel 1,3,4-oxadiazole derivatives, characterize their chemical structures using spectroscopic techniques, and evaluate their in vitro antimicrobial activity against selected bacterial and fungal pathogens. Methods: Novel 1,3,4-oxadiazole derivatives were synthesized through a multistep synthetic protocol and purified by recrystallization. Structural confirmation of the synthesized compounds was performed using Fourier Transform Infrared (FTIR) spectroscopy, Proton Nuclear Magnetic Resonance (^1H NMR), Carbon-13 Nuclear Magnetic Resonance (^13C NMR), and Mass Spectrometry (MS). The antimicrobial activity was assessed in vitro against selected Gram-positive bacteria (Staphylococcus aureus and Bacillus subtilis), Gram-negative bacteria (Escherichia coli), and fungal strains (Candida albicans and Aspergillus niger) using the agar well diffusion method. Compounds demonstrating antimicrobial activity were further evaluated for their minimum inhibitory concentration (MIC) by the broth dilution method. Ciprofloxacin and fluconazole served as the reference antibacterial and antifungal drugs, respectively. These synthesis, characterization, and assay methods are consistent with the methodology described in the dissertation. Results: The synthesized compounds were successfully obtained and structurally characterized by spectroscopic analyses, confirming the formation of the desired 1,3,4-oxadiazole framework. Antimicrobial screening revealed variable activity among the synthesized derivatives, with several compounds exhibiting appreciable antibacterial and antifungal effects. The observed activity indicated that structural substitution on the oxadiazole nucleus influenced antimicrobial potency, suggesting that appropriate aromatic substituents may enhance biological activity. Conclusion: The present study demonstrates that novel 1,3,4-oxadiazole derivatives constitute promising heterocyclic scaffolds with significant antimicrobial potential. The combination of successful synthesis, structural characterization, and encouraging in vitro antimicrobial activity highlights their potential for further optimization. Additional studies involving molecular docking, toxicity evaluation, pharmacokinetic profiling, and in vivo investigations are warranted to establish their suitability as prospective antimicrobial drug candidates.

Keywords: 1,3,4-Oxadiazole; Heterocyclic compounds; Antimicrobial activity; Antibacterial activity; Antifungal activity; Spectral characterization; FTIR; ^1H NMR; ^13C NMR; Mass spectrometry.